Helicos BioSciences (FRA:HB4) PB Ratio : (As of Jun. 22, 2024)

View and export this data going back to . Start your Free Trial

What is Helicos BioSciences PB Ratio?

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2024-06-22), Helicos BioSciences's share price is €0.12. Helicos BioSciences's Book Value per Share for the quarter that ended in Dec. 2011 was €-0.10. Hence, Helicos BioSciences's PB Ratio of today is .

The historical rank and industry rank for Helicos BioSciences's PB Ratio or its related term are showing as below:

FRA:HB4's PB Ratio is not ranked ^*
in the Drug Manufacturers industry.
Industry Median: 1.895
* Ranked among companies with meaningful PB Ratio only.

Back to Basics: PB Ratio

Helicos BioSciences PB Ratio Historical Data

The historical data trend for Helicos BioSciences's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Helicos BioSciences PB Ratio Chart

Helicos BioSciences Annual Data

Trend

Dec05

Dec06

Dec07

Dec08

Dec09

Dec10

Dec11

PB Ratio

Get a 7-Day Free Trial

Helicos BioSciences Semi-Annual Data
	Dec04	Dec05	Dec06	Dec07	Dec08	Dec09	Dec10	Dec11
PB Ratio	Get a 7-Day Free Trial			-	-	-	-	-

Competitive Comparison of Helicos BioSciences's PB Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Helicos BioSciences's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Helicos BioSciences's PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Helicos BioSciences's PB Ratio distribution charts can be found below:

* The bar in red indicates where Helicos BioSciences's PB Ratio falls into.

Helicos BioSciences PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

Helicos BioSciences's PB Ratio for today is calculated as follows:

PB Ratio	=	Share Price	/	Book Value per Share (Q: Dec. 2011)
	=	0.12	/	-0.095
	=

It can also be calculated from the numbers for the whole company:

PB Ratio

Market Cap

(Total Stockholders Equity

Preferred Stock)

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.

Helicos BioSciences (FRA:HB4) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.

Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.

Helicos BioSciences PB Ratio Related Terms

Thank you for viewing the detailed overview of Helicos BioSciences's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.

Helicos BioSciences (FRA:HB4) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Helicos BioSciences Corp (FRA:HB4) » Definitions » PB Ratio

Comparable Companies

Traded in Other Exchanges

N/A

Address

Website

Helicos BioSciences Corp is incorporated in the state of Delaware and was incorporated on May 9, 2003. It is a life sciences company focused on genetic analysis technologies for the research, drug discovery and clinical diagnostics markets. The Company's products are based on its proprietary True Single Molecule Sequencing (tSMS) technology which enables rapid analysis of large quantities of genetic material by directly sequencing single molecules of DNA or single DNA copies of RNA. The Company's Helicos Genetic Analysis Platform is designed to obtain sequencing information by repetitively performing a cycle of biochemical reactions on individual DNA molecules and imaging the results after each cycle. The platform consists of an instrument called the HeliScope Single Molecule Sequencer, an image analysis computer tower called the HeliScope Analysis Engine, associated reagents, which are chemicals used in the sequencing process, and disposable supplies. The Company is subject, both directly and indirectly, to the adverse impact of existing and potential future government regulation of its operations and markets.

Helicos BioSciences (FRA:HB4) Headlines

No Headlines